Xtx Topco LTD Biocryst Pharmaceuticals Inc Transaction History
Xtx Topco LTD
- $1.12 Billion
- Q2 2024
A detailed history of Xtx Topco LTD transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Xtx Topco LTD holds 156,946 shares of BCRX stock, worth $1.19 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
156,946
Previous 39,339
298.96%
Holding current value
$1.19 Million
Previous $199,000
386.93%
% of portfolio
0.09%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$152 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$143 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$95.5 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$71 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$67.1 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.41B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...